HLNE
Hamilton Lane Incorporated
Set alert
- YTD
- -37.53%
- 1 year
- -26.46%
- Open
- 84.87
- Prev close
- 85.66
- Mkt cap
- 5.62B
- Vol
- 419.72K
- Avg vol
- 638.31K
- EPS
- 6.56
- P/E
- 12.79
- Div yield
- 2.80%
More statistics
- Low
- 82.96
- High
- 85.70
- Forward P/E
- 11.38
- Beta
- 1.25
- Short ratio
- 5.89
- Inst. own
- 112.48%
- Dividend
- 2.40
- Ex-div date
- Sep 20, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 91.38
- 200-d avg
- 97.86
- 1y target
- 123.13
Key statistics
- Market cap
- 5.62B
- Enterprise value
- 4.45B
- Trailing P/E
- 12.79
- Forward P/E
- 11.38
- PEG ratio
- 0.00
- Price / sales
- 6.55
- Price / book
- 3.83
- EPS (TTM)
- 6.56
- Beta
- 1.25
- Dividend yield
- 2.80%
- Payout ratio
- 33.84%
- Profit margin
- 32.14%
- Revenue (TTM)
- 858.37M
- Revenue growth
- 56.50%
- Free cash flow
- 231.40M
- Total cash
- 337.02M
- Total debt
- 364.79M
- Return on equity
- 32.42%
- Shares outstanding
- 43.35M
- Short % of float
- 11.29%
- 50-day average
- 91.38
- 200-day average
- 97.86
Analyst view
Consensus: strong buy
- Target (low)
- 95.00
- Target (mean)
- 123.13
- Target (high)
- 171.00
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 1.67.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 1.65 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 1.53 | 1.94 | +0.41 | +26.80% |
| May 21, 2026 | Mar 31, 2026 | 1.43 | 1.49 | +0.06 | +4.20% |
| Feb 3, 2026 | Dec 31, 2025 | 1.35 | 1.55 | +0.20 | +14.81% |
| Nov 4, 2025 | Sep 30, 2025 | 1.08 | 1.54 | +0.46 | +42.59% |
| Aug 5, 2025 | Jun 30, 2025 | 0.98 | 1.31 | +0.33 | +33.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | BMO Capital | main | Outperform | Outperform |
| Oct 13, 2026 | UBS | main | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | init | — | Overweight |
| Aug 27, 2026 | Oppenheimer | main | Outperform | Outperform |
| Aug 5, 2026 | UBS | main | Buy | Buy |
| Aug 5, 2026 | Oppenheimer | main | Outperform | Outperform |
About Hamilton Lane Incorporated
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets. For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnarounds, mezzanine and venture capital funds. The firm prefers to invest in disruptive technologies and innovative companies. It prefers to invest in space, engine, alternative energy resources, environmental & facilities services, households durables, leisure products, textiles, manufacturing services, water purification, online training service, healthcare services & technology, energy, industrials, commercial services, internet software & services, consumer discretionary, health care, real estate, information technology, tech-enabled businesses, financials, utilities, and consumer services. The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Southeast Asia, Korea, China, India, Latin America and Caribbean, United States of America, New York, Florida, Arizona, Nevada, New Mexico, Oregon, Washington, California and surrounding states, Australia, Japan, Brazil, United Kingdom, and Canada. The firm prefers to invest between $0.25 million and $100 million in companies with small- to mid-sized enterprise values. It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Philadelphia, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
- Website
- hamiltonlane.com
News
- Hamilton Lane (HLNE) Could Be a Great Choice
- Weatherbie Specialized Growth Fund Q3 2026 Portfolio Update
- BMO Capital Maintains Outperform on Hamilton Lane, Lowers Price Target to $95
- Hamilton Lane (HLNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- FDA approves Cosette Pharmaceuticals' EVOXAC
- UBS Maintains Buy on Hamilton Lane, Lowers Price Target to $115
- Wells Fargo Initiates Coverage On Hamilton Lane with Overweight Rating, Announces Price Target of $103
- Oppenheimer Maintains Outperform on Hamilton Lane, Lowers Price Target to $181
- UBS Maintains Buy on Hamilton Lane, Raises Price Target to $131
- Oppenheimer Maintains Outperform on Hamilton Lane, Raises Price Target to $182
Your note
Sign in to keep a note on HLNE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARMBRISTER JEFFREY BRIAN | Chief Financial Officer | Stock Award(Grant) | May 28, 2026 | 12,958 |
| BERKMAN DAVID J | Director | Purchase | Jun 10, 2026 | 0 |
| DELGADO-MOREIRA JUAN | Chief Executive Officer | Stock Gift | Sep 9, 2026 | 1,376,130 |
| FRENCH RIVER 5 LTD | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 3, 2025 | 330,015 |
| GAVALIS LYDIA A. | General Counsel | Stock Award(Grant) | May 28, 2026 | 34,028 |
| HIRSCH ERIK R | Chief Executive Officer | Stock Award(Grant) | May 28, 2026 | 105,727 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.88% | 4,281,385 | 359.29M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 7.04% | 3,053,076 | 256.21M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.14% | 1,796,500 | 150.76M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.14% | 1,794,120 | 150.56M | Jun 29, 2026 |
| Wasatch Advisors LP | 3.35% | 1,452,376 | 121.88M | Sep 29, 2026 |
| State Street Corporation | 3.13% | 1,355,756 | 113.78M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.27% | 1,417,414 | 118.95M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.89% | 1,252,886 | 105.14M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.08% | 900,290 | 75.55M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.20% | 521,390 | 43.76M | Jun 29, 2026 |
| Virtus Equity Trust-Virtus KAR Mid-Cap Core Fund | 1.12% | 485,086 | 40.71M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.08% | 469,145 | 39.37M | Jun 29, 2026 |